advertisement
See also comment(s) by Chris Johnson •
PURPOSE: Contrast sensitivity sometimes increases in patients with open-angle glaucoma when intraocular pressure (IOP) is decreased. Although often interpreted as demonstrating reversible glaucoma-induced dysfunction, this result, if true, could simply reflect a general relationship between sensitivity and IOP in visual mechanisms unaffected by glaucoma. To investigate this relationship, we test the hypothesis that reducing IOP in eyes without glaucoma (ocular hypertension) does not increase perimetric contrast sensitivity. DESIGN: Comparative case series. PARTICIPANTS: A total of 692 participants drawn from the Ocular Hypertension Treatment Study (OHTS) (22 clinical centers). METHODS: Commercially available topical ocular hypotensive medications. MAIN OUTCOME MEASURES: Post hoc analysis of IOP and perimetric contrast sensitivity (mean deviation [MD] and pattern standard deviation [PSD]) both at baseline (0 months, immediately before ocular antihypertensive therapy) and at 6-month review. An additional 618 control eyes from OHTS that did not receive treatment were examined over the same period. Data from the second phase of OHTS also were examined, and control eyes then received treatment. RESULTS: Treated eyes had a decrease in IOP at 6 months (5.1 mmHg, P<0.001) but no significant change in MD (0.04 decibels [dB], P = 0.59) or PSD (0.03 dB, P = 0.19), relative to controls. A similar decrease in IOP was found for eyes that began treatment in the second phase of OHTS, but no significant change in MD or PSD. CONCLUSIONS: Despite using a large sample size, we found no relationship between perimetric contrast sensitivity and IOP reduction in ocular hypertension, which suggests that previous sensitivity changes seen in patients with glaucoma, if true, are indicative of reversible glaucoma-induced dysfunction rather than a general relationship between sensitivity and IOP in visual mechanisms unaffected by glaucoma.
Full article
13.2.2.2 Improvement (Part of: 13 Therapeutic prognosis and outcome > 13.2 Outcome > 13.2.2 Visual field)
6.20 Progression (Part of: 6 Clinical examination methods)